A. Scheschonka

发表

Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study

J. Wissel, K. Fheodoroff, A. Scheschonka, 2020, Disability and rehabilitation.

Expression of GTPase-deficient Giα2 Results in Translocation of Cytoplasmic RGS4 to the Plasma Membrane*

Dennis Brown, K. Blumer, K. Druey, 1998, The Journal of Biological Chemistry.

Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials

P. Riederer, W. Danysz, A. Dekundy, 2021, Journal of Neural Transmission.

Knock-In Mice Lacking the PDZ-Ligand Motif of mGluR7a Show Impaired PKC-Dependent Autoinhibition of Glutamate Release, Spatial Working Memory Deficits, and Increased Susceptibility to Pentylenetetrazol

J. Bockaert, L. Fagni, H. Betz, 2008, The Journal of Neuroscience.

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

J. Wissel, D. Dressler, D. Simpson, 2020, Health and Quality of Life Outcomes.

RGS3 is a GTPase-activating protein for g(ialpha) and g(qalpha) and a potent inhibitor of signaling by GTPase-deficient forms of g(qalpha) and g(11alpha).

C. Dessauer, P. Chidiac, C. Shi, 2000, Molecular pharmacology.

Electroconvulsive therapy and anticoagulation.

E. Rüther, S. Bleich, D. Degner, 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Regulator of G Protein Signaling 1 (RGS1) Markedly Impairs Giα Signaling Responses of B Lymphocytes

C. Moratz, K. Druey, T. Kozasa, 2000, The Journal of Immunology.

RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain.

R. Bodnar, J. Niu, T. Voyno-Yasenetskaya, 2002, The Biochemical journal.

Potential role for a regulator of G protein signaling (RGS3) in gonadotropin-releasing hormone (GnRH) stimulated desensitization.

K. Druey, L. W. Duck, L. Musgrove, 1997, Endocrinology.

Pre- and posttreatment MR imaging in AIDS-related Kaposi sarcoma of the conjunctiva and lacrimal gland.

F. Zanella, M. Mösch, B. Turowski, 2003, AJNR. American journal of neuroradiology.

Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin

W. Beuche, A. Scheschonka, 2003, Pain.

Pias1 Interaction and Sumoylation of Metabotropic Glutamate Receptor 8*

H. Betz, Zhongshu Tang, O. Far, 2005, Journal of Biological Chemistry.

Protein interactions in the sumoylation cascade – lessons from X‐ray structures

Heinrich Betz, H. Betz, Zhongshu Tang, 2008, The FEBS journal.

Metabotropic glutamate receptor 4 interacts with microtubule-associated protein 1B.

M. Karas, H. Betz, Tobias Beckhaus, 2009, Biochemical and biophysical research communications.

Sumoylation in neurons: nuclear and synaptic roles?

H. Betz, Zhongshu Tang, A. Scheschonka, 2007, Trends in Neurosciences.

Increases in Intracellular Calcium Triggered by Channelrhodopsin-2 Potentiate the Response of Metabotropic Glutamate Receptor mGluR7*

J. Caldwell, E. Bamberg, G. Nagel, 2008, Journal of Biological Chemistry.

PICK1 uncoupling from mGluR7a causes absence-like seizures

R. Huganir, P. Marin, J. Bockaert, 2008, Nature Neuroscience.

Temporal relationships between the loss of vitamin E, protein sulfhydryls and lipid peroxidation in microsomes challenged with different prooxidants.

H. Sies, M. Murphy, A. Scheschonka, 1990, Chemico-biological interactions.

Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects

J. Jankovic, D. Mitsikostas, A. Dekundy, 2021, Current medical research and opinion.

Regulation of Chemotactic and Proadhesive Responses to Chemoattractant Receptors by RGS (Regulator of G-protein Signaling) Family Members*

E. Butcher, K. Druey, J. Kehrl, 1998, The Journal of Biological Chemistry.

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis

J. Wissel, D. Simpson, A. Camões-Barbosa, 2021, Toxins.

Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus.

J. Wissel, D. Dressler, D. Simpson, 2020, Annals of physical and rehabilitation medicine.

POST HOC ANALYSIS OF THE IMPROVEMENT IN SHOULDER SPASTICITY AND SAFETY OBSERVED FOLLOWING TREATMENT WITH INCOBOTULINUMTOXINA

J. Wissel, D. Simpson, D. Bensmail, 2020 .

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity

F. Molteni, J. Wissel, D. Dressler, 2017, Neurology.

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity The TOWER study

F. Molteni, J. Wissel, D. Dressler, 2022 .

RGS 3 Is a GTPase-Activating Protein for Gi a and Gq a and a Potent Inhibitor of Signaling by GTPase-Deficient Forms of Gq a and G 11 a

C. Dessauer, P. Chidiac, C. Shi, 2000 .

Structural Determinants of Calmodulin Binding to the Intracellular C-terminal Domain of the Metabotropic Glutamate Receptor 7A*

J. Caldwell, V. O'Connor, H. Betz, 2008, Journal of Biological Chemistry.

Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis

A. Albanese, J. Wissel, H. Jinnah, 2023, Toxins.

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis

K. Fheodoroff, Matteo Vacchelli, M. Althaus, 2023, Toxins.

Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study

M. Jog, D. Simpson, Farooq Ismail, 2020, Toxins.